165 related articles for article (PubMed ID: 30553276)
21. Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells.
Ahn K; O YM; Ji YG; Cho HJ; Lee DH
Yonsei Med J; 2018 Aug; 59(6):727-735. PubMed ID: 29978609
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.
Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X
Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967
[TBL] [Abstract][Full Text] [Related]
23. Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.
Yamaguchi Y; Takenobu H; Ohira M; Nakazawa A; Yoshida S; Akita N; Shimozato O; Iwama A; Nakagawara A; Kamijo T
Eur J Cancer; 2014 May; 50(8):1555-65. PubMed ID: 24559687
[TBL] [Abstract][Full Text] [Related]
24. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
25. Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3.
Yang S; Zhang L; Purohit V; Shukla SK; Chen X; Yu F; Fu K; Chen Y; Solheim J; Singh PK; Song W; Dong J
Oncotarget; 2015 Nov; 6(34):36019-31. PubMed ID: 26440309
[TBL] [Abstract][Full Text] [Related]
26. p31comet Induces cellular senescence through p21 accumulation and Mad2 disruption.
Yun M; Han YH; Yoon SH; Kim HY; Kim BY; Ju YJ; Kang CM; Jang SH; Chung HY; Lee SJ; Cho MH; Yoon G; Park GH; Kim SH; Lee KH
Mol Cancer Res; 2009 Mar; 7(3):371-82. PubMed ID: 19276188
[TBL] [Abstract][Full Text] [Related]
27. Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis.
Kalitsis P; Earle E; Fowler KJ; Choo KH
Genes Dev; 2000 Sep; 14(18):2277-82. PubMed ID: 10995385
[TBL] [Abstract][Full Text] [Related]
28. The Drosophila Bub3 protein is required for the mitotic checkpoint and for normal accumulation of cyclins during G2 and early stages of mitosis.
Lopes CS; Sampaio P; Williams B; Goldberg M; Sunkel CE
J Cell Sci; 2005 Jan; 118(Pt 1):187-98. PubMed ID: 15615783
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers.
Haruki N; Saito H; Harano T; Nomoto S; Takahashi T; Osada H; Fujii Y; Takahashi T
Cancer Lett; 2001 Jan; 162(2):201-5. PubMed ID: 11146226
[TBL] [Abstract][Full Text] [Related]
31. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.
Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
[TBL] [Abstract][Full Text] [Related]
32. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
[TBL] [Abstract][Full Text] [Related]
33. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK.
Summy JM; Trevino JG; Baker CH; Gallick GE
Pancreas; 2005 Oct; 31(3):263-74. PubMed ID: 16163059
[TBL] [Abstract][Full Text] [Related]
34. Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer.
Liu X; Guo X; Li H; Chen J; Qi X
Mol Med Rep; 2016 Jun; 13(6):4774-8. PubMed ID: 27082851
[TBL] [Abstract][Full Text] [Related]
35. RGS6 interacts with DMAP1 and DNMT1 and inhibits DMAP1 transcriptional repressor activity.
Liu Z; Fisher RA
J Biol Chem; 2004 Apr; 279(14):14120-8. PubMed ID: 14734556
[TBL] [Abstract][Full Text] [Related]
36. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass.
Yang CC; Fazli L; Loguercio S; Zharkikh I; Aza-Blanc P; Gleave ME; Wolf DA
Oncotarget; 2015 Sep; 6(26):22060-71. PubMed ID: 26091350
[TBL] [Abstract][Full Text] [Related]
38. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
[TBL] [Abstract][Full Text] [Related]
39. Retention of the BUB3 checkpoint protein on lagging chromosomes.
Martinez-Exposito MJ; Kaplan KB; Copeland J; Sorger PK
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8493-8. PubMed ID: 10411903
[TBL] [Abstract][Full Text] [Related]
40. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
